Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 3
1988 3
1989 3
1990 4
1991 2
1992 5
1993 1
1994 5
1995 4
1996 2
1997 2
1998 3
1999 6
2000 8
2001 3
2002 6
2003 8
2004 11
2005 3
2006 6
2007 7
2008 9
2009 9
2010 4
2012 2
2013 3
2014 2
2015 2
2016 1
2017 1
2018 2
2019 1
2020 2
2022 1
2023 1
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
10-year follow-up of intensive glucose control in type 2 diabetes.
Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. Holman RR, et al. Among authors: neil ha. N Engl J Med. 2008 Oct 9;359(15):1577-89. doi: 10.1056/NEJMoa0806470. Epub 2008 Sep 10. N Engl J Med. 2008. PMID: 18784090 Free article. Clinical Trial.
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH; CARDS investigators. Colhoun HM, et al. Among authors: neil ha. Lancet. 2004 Aug 21-27;364(9435):685-96. doi: 10.1016/S0140-6736(04)16895-5. Lancet. 2004. PMID: 15325833 Clinical Trial.
ASCEND-Eye: Effects of Aspirin on Diabetic Retinopathy.
Sammons EL, Buck G, Bowman LJ, Stevens WM, Hammami I, Parish S, Armitage J; ASCEND Study Collaborative Group. Sammons EL, et al. Ophthalmology. 2024 Jul;131(7):771-779. doi: 10.1016/j.ophtha.2024.01.018. Epub 2024 Jan 17. Ophthalmology. 2024. PMID: 38237868 Clinical Trial.
ASCEND-Eye: Effects of Omega-3 Fatty Acids on Diabetic Retinopathy.
Sammons EL, Buck G, Bowman LJ, Stevens WM, Hammami I, Parish S, Armitage J; ASCEND Study Collaborative Group. Sammons EL, et al. Ophthalmology. 2024 May;131(5):526-533. doi: 10.1016/j.ophtha.2023.11.030. Epub 2023 Dec 3. Ophthalmology. 2024. PMID: 38052385 Clinical Trial.
A new strategy for vascular complications in young people with type 1 diabetes mellitus.
Marcovecchio ML, Dalton RN, Daneman D, Deanfield J, Jones TW, Neil HAW, Dunger DB; Adolescent type 1 Diabetes cardio-renal Intervention Trial (AdDIT) study group. Marcovecchio ML, et al. Among authors: neil haw. Nat Rev Endocrinol. 2019 Jul;15(7):429-435. doi: 10.1038/s41574-019-0198-2. Nat Rev Endocrinol. 2019. PMID: 30996294 Review.
Sulphonylureas and hypoglycaemia.
Ferner RE, Neil HA. Ferner RE, et al. Among authors: neil ha. Br Med J (Clin Res Ed). 1988 Apr 2;296(6627):949-50. doi: 10.1136/bmj.296.6627.949. Br Med J (Clin Res Ed). 1988. PMID: 3129103 Free PMC article. No abstract available.
Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.
Hartweg J, Perera R, Montori V, Dinneen S, Neil HA, Farmer A. Hartweg J, et al. Among authors: neil ha. Cochrane Database Syst Rev. 2008 Jan 23;2008(1):CD003205. doi: 10.1002/14651858.CD003205.pub2. Cochrane Database Syst Rev. 2008. PMID: 18254017 Free PMC article. Review.
129 results